Syros Pharmaceuticals Appoints Vicki L. Sato, Ph.D., to Board of Directors
9/5/2013 9:23:21 AM
Syros Pharmaceuticals, a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today the appointment of Vicki L. Sato, Ph.D., to its Board of Directors. Dr. Sato is a Professor of Management Practice at Harvard Business School, and Professor of the Practice in the Department of Molecular and Cell Biology at Harvard University. She was previously President of Vertex Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
comments powered by